Top

World Journal of Urology

Published in:

01-05-2015 | Invited Review

Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature

Authors: Pietro Castellan, Roberto Castellucci, Luigi Schips, Luca Cindolo

Published in: World Journal of Urology | Issue 5/2015

Abstract

Purpose

The aim of this study is to investigate the efficacy and safety of 180-W XPS GreenLight laser technology for photoselective prostate vaporization.

Patients and methods

A systematic search of the electronic databases was performed. Inclusion criteria were: full-text peer-reviewed journal article, with original data analysis that evaluates the feasibility and the outcome only of 180-W XPS GL laser system. Data at baseline and during follow-up have been taken into account. Intra-operative and postoperative (functional results and complications) data were collected and analyzed.

Results

We found 165 articles in our research, among which only nine articles were selected (total 991 patients). A certain grade of variability is present in all the studies in terms of scientific design, sample size and methods of reporting functional results and complications. Nevertheless, a homogenous benefit for patients in terms of symptom score improvement, post-void residual volume reduction and urinary max flow rate improvement was shown. According to Clavien–Dindo classification, 292 (83.7 %) adverse events were recorded ≤ grade 2. Adverse events ≥ grade 3 were 57 (16.3 %), among which bleeding, urinary retention and residual obstructive tissue represented the wide majority. No mortality was reported. Male sexual function was poorly investigated.

Conclusions

The 180-W XPS GL laser technique is feasible and safe, with a remarkable clinical benefit. Long-term evidence on outcomes and complications are suitable even in the sphere of male sexuality.

Oelke M, Bachmann A, Descazeaud A et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64:118–140. doi:10.1016/j.eururo.2013.03.004 CrossRefPubMed

Kirby RS (2000) The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 56:3–6CrossRefPubMed

Herrmann TRW, Liatsikos EN, Nagele U et al (2012) EAU guidelines on laser technologies. Eur Urol 61:783–795. doi:10.1016/j.eururo.2012.01.010 CrossRefPubMed

Sountoulides P, Tsakiris P (2008) The evolution of KTP laser vaporization of the prostate. Yonsei Med J 49:189–199. doi:10.3349/ymj.2008.49.2.189 CrossRefPubMedCentralPubMed

Ben-Zvi T, Hueber P-A, Liberman D et al (2013) GreenLight XPS 180 W vs HPS 120 W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study. Urology 81:853–858. doi:10.1016/j.urology.2012.12.031 CrossRefPubMed

Bachmann A, Tubaro A, Barber N et al (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial—the GOLIATH study. Eur Urol 65:931–942. doi:10.1016/j.eururo.2013.10.040 CrossRefPubMed

Bachmann A, Tubaro A, Barber N et al (2014) An European multicenter randomized noninferiority trial comparing 180-W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-months results of the GOLIATH-study. J Urol. doi:10.1016/j.juro.2014.09.001 PubMed

Chung ASJ, Chabert C, Yap H-W et al (2012) Photoselective vaporization of the prostate using the 180 W lithium triborate laser. ANZ J Surg 82:334–337. doi:10.1111/j.1445-2197.2012.06038.x CrossRefPubMed

Campbell NA, Chung ASJ, Yoon PD et al (2013) Early experience photoselective vaporisation of the prostate using the 180 W lithium triborate and comparison with the 120 W lithium triborate laser. Prostate Int 1:42–45. doi:10.12954/PI.12006 CrossRefPubMedCentralPubMed

10.

Bachmann A, Muir GH, Collins EJ et al (2012) 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol 61:600–607. doi:10.1016/j.eururo.2011.11.041 CrossRefPubMed

11.

Muir G, Gómez Sancha F, Bachmann A et al (2008) Techniques and training with GreenLight HPS 120-W laser therapy of the prostate: position paper. Eur Urol Suppl 7:370–377. doi:10.1016/j.eursup.2008.01.012 CrossRef

12.

Zorn KC, Liberman D (2011) GreenLight 180 W XPS photovaporization of the prostate: how I do it. Can J Urol 18:5918–5926PubMed

13.

Misraï V, Faron M, Guillotreau J et al (2014) Assessment of the learning curves for photoselective vaporization of the prostate using GreenLight™ 180-Watt-XPS laser therapy: defining the intra-operative parameters within a prospective cohort. World J Urol 32:539–544. doi:10.1007/s00345-013-1163-7 CrossRefPubMed

14.

Malek RS, Kuntzman RS, Barrett DM (2000) High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 163:1730–1733CrossRefPubMed

15.

Altay B, Erkurt B, Kiremit MC et al (2014) 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci. doi:10.1007/s10103-014-1667-4 PubMed

16.

Emara AM, Barber NJ (2014) The continuous evolution of the GreenLight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol Endourol Soc 28:73–78. doi:10.1089/end.2013.0356 CrossRef

17.

Rieken M, Bonkat G, Müller G et al (2013) The effect of increased maximum power output on perioperative and early postoperative outcome in photoselective vaporization of the prostate. Lasers Surg Med 45:28–33. doi:10.1002/lsm.22108 CrossRefPubMed

18.

Benejam-Gual JM, Sanz-Granda Á, Budía A et al (2014) Estudio multicéntrico de costes de 2 técnicas quirúrgicas: láser GreenLight XPS 180 W vs resección transuretral de la próstata. Actas Urol Esp 38:373–377. doi:10.1016/j.acuro.2013.10.011 PubMed

19.

Naspro R, Bachmann A, Gilling P et al (2009) A review of the recent evidence (2006–2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. Eur Urol 55:1345–1357. doi:10.1016/j.eururo.2009.03.070 CrossRefPubMed

20.

Mitropoulos D, Artibani W, Graefen M et al (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol 61:341–349. doi:10.1016/j.eururo.2011.10.033 CrossRefPubMed

21.

Bruyère F (2011) The relationship between photoselective vaporization of the prostate and sexual function. Curr Urol Rep 12:261–264. doi:10.1007/s11934-011-0199-8 CrossRefPubMed

22.

Bruyère F, Puichaud A, Pereira H et al (2010) Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 58:207–211. doi:10.1016/j.eururo.2010.04.027 CrossRefPubMed

23.

Hossack TA, Woo HH (2012) Sexual function outcome following photoselective vaporisation of the prostate. Int Urol Nephrol 44:359–364. doi:10.1007/s11255-011-0029-4 CrossRefPubMed

Title: Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature
Authors: Pietro Castellan
Roberto Castellucci
Luigi Schips
Luca Cindolo
Publication date: 01-05-2015
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 5/2015
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-015-1490-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature

Abstract

Purpose

Patients and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Patients and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2015

Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer

Circumcision plus antibiotic, anti-inflammatory, and α-blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, multicenter trial

Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study

Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?

Surgical team composition has a major impact on effectiveness and costs in laparoscopic donor nephrectomy

Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey